Hasan C. Yildirim-Yıldırım - Publications

First-Line Durvalumab-Tremelimumab in Advanced Hepatocellular Carcinoma: Real-World Data from Turkey.

Journal: Journal of clinical medicine

Published: June 24, 2026

Comparison of Neoadjuvant TCHP and ddAC+THP Regimens for Pathologic Complete Response in HER2-Positive Breast Cancer: A Multicenter Real-World Analysis of Systemic Inflammatory Biomarkers.

Journal: Medicina (Kaunas, Lithuania)

Published: June 08, 2026

Impact of adjuvant endocrine therapy on disease-free survival in early triple-positive breast cancer: a multicenter retrospective cohort study of the Turkish oncology group.

Journal: BMC cancer

Published: June 04, 2026

Valorization of Construction and Demolition Wastes and Industrial By-Products in Sustainable Concrete: Comparative Mechanical Performance of Slag Slurry-Treated Recycled Aggregate Concretes.

Journal: Materials (Basel, Switzerland)

Published: May 18, 2026

Demographic Characteristics, Clinical Features, and Treatment Patterns of Classic and AIDS-Related Kaposi Sarcoma: A Multicenter Real-World Study from Turkey.

Journal: Medicina (Kaunas, Lithuania)

Published: May 03, 2026

The temporal evaluation of RAS mutation by liquid biopsy at progression after bevacizumab-based treatment in patients with metastatic colorectal cancer.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: May 02, 2026

Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study.

Journal: Current oncology (Toronto, Ont.)

Published: May 02, 2026

First-Line Treatment After Perioperative FLOT in Recurrent Gastric and Gastroesophageal Junction Cancer: A Turkish Oncology Group (TOG) Multicenter Real-World Analysis.

Journal: Medicina (Kaunas, Lithuania)

Published: April 15, 2026

Clinical Significance of Achieving No Evidence of Disease in HER2-Positive Metastatic Breast Cancer: A Multicenter Study by Turkish Oncology Group (TOG).

Journal: Cancers

Published: February 12, 2026

Current Vaccination Principles and Practices in Adult Cancer Patients.

Journal: Journal of clinical practice and research

Published: February 12, 2026

Outcomes of First-Line PARP Inhibitor Therapy in Ovarian Cancer: A Multicenter Retrospective Analysis.

Journal: Journal of clinical medicine

Published: February 01, 2026

The Prognostic Role of Inflammation on Hepatocellular Carcinoma.

Journal: Cancer diagnosis & prognosis

Published: December 22, 2025